Barrington Research Cuts Concentrix (NASDAQ:CNXC) Price Target to $38.00

Concentrix (NASDAQ:CNXC) had its price objective reduced by research analysts at Barrington Research from $62.00 to $38.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Barrington Research’s price target indicates a potential upside of 46.05% from the stock’s current price.

Other research analysts have also recently issued research reports about the stock. Robert W. Baird decreased their price objective on shares of Concentrix from $52.00 to $40.00 and set an “outperform” rating for the company in a report on Wednesday. Weiss Ratings lowered shares of Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a report on Thursday, January 29th. Wall Street Zen raised Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Finally, Canaccord Genuity Group decreased their target price on Concentrix from $80.00 to $55.00 and set a “buy” rating for the company in a research note on Wednesday. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $48.50.

Concentrix Trading Down 1.7%

NASDAQ CNXC traded down $0.46 on Wednesday, reaching $26.02. The company had a trading volume of 924,504 shares, compared to its average volume of 1,446,836. Concentrix has a 52 week low of $24.27 and a 52 week high of $66.00. The stock’s 50 day moving average is $35.34 and its 200-day moving average is $40.33. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.67. The stock has a market cap of $1.60 billion, a price-to-earnings ratio of -1.25, a PEG ratio of 0.35 and a beta of 0.50.

Concentrix (NASDAQ:CNXC) last issued its earnings results on Tuesday, March 24th. The company reported $2.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.03). The company had revenue of $2.50 billion for the quarter, compared to the consensus estimate of $2.49 billion. Concentrix had a positive return on equity of 16.91% and a negative net margin of 13.02%.Concentrix’s quarterly revenue was up 5.4% on a year-over-year basis. During the same quarter last year, the business posted $2.79 EPS. Equities analysts predict that Concentrix will post 10.11 earnings per share for the current year.

Insider Activity

In other news, CEO Christopher A. Caldwell purchased 1,000 shares of the business’s stock in a transaction dated Thursday, January 29th. The shares were bought at an average cost of $37.07 per share, for a total transaction of $37,070.00. Following the completion of the acquisition, the chief executive officer directly owned 362,075 shares in the company, valued at approximately $13,422,120.25. This trade represents a 0.28% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.90% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Concentrix

Large investors have recently bought and sold shares of the company. Huntington National Bank lifted its position in shares of Concentrix by 6,011.1% in the third quarter. Huntington National Bank now owns 550 shares of the company’s stock worth $25,000 after purchasing an additional 541 shares in the last quarter. Geneos Wealth Management Inc. increased its stake in Concentrix by 532.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after buying an additional 522 shares during the last quarter. Quent Capital LLC acquired a new stake in Concentrix in the 3rd quarter valued at $29,000. Larson Financial Group LLC lifted its position in Concentrix by 224.9% during the 3rd quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock worth $32,000 after buying an additional 479 shares in the last quarter. Finally, Rothschild Investment LLC boosted its stake in shares of Concentrix by 14,980.0% during the 3rd quarter. Rothschild Investment LLC now owns 754 shares of the company’s stock worth $35,000 after buying an additional 749 shares during the last quarter. Institutional investors and hedge funds own 90.34% of the company’s stock.

Key Concentrix News

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Company maintained full‑year and Q2 guidance and highlighted AI / iX Suite wins and banking growth, signaling continued commercial momentum and predictable revenue outlook. GlobeNewswire Q1 Release
• Positive Sentiment: Board declared a $0.36 quarterly dividend (5.3% yield) payable May 5 (ex‑dividend Apr 24) and the company repurchased ~1M shares in Q1 with ~$396.6M left on the authorization — shareholder returns that can support the stock. Dividend & Repurchase Details
• Neutral Sentiment: Top‑line held up: revenue increased 5.4% year‑over‑year ($2.50B) and roughly in line with consensus — a stabilizing data point even as margins slipped. Revenue & Guidance
• Negative Sentiment: GAAP profitability declined sharply: net income fell ~69% and diluted EPS fell to $0.33 from $1.04 year‑ago; operating margin and adjusted EBITDA margin contracted materially — profitability weakness is the main driver of the sell‑off. Q1 Results
• Negative Sentiment: Cash flow concerns: operating cash flow was negative and adjusted free cash flow was a use in the quarter, which raises near‑term liquidity/coverage questions despite the company’s guidance and buyback room. Cash Flow & Financials
• Negative Sentiment: Analysts trimmed price targets: Canaccord cut its target (from $80 to $55) while keeping a Buy rating and Robert W. Baird lowered its target (from $52 to $40) but kept an Outperform — PT cuts reduce upside expectations and can pressure the share price. Benzinga: Canaccord Benzinga: Baird
• Negative Sentiment: Market skepticism / bear commentary: critical investor pieces question valuation and execution despite low multiples, adding to investor caution (example: Seeking Alpha note). Seeking Alpha: Why I’m Not Buying

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.